The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Membrane-damaging antimicrobial agents have great potential to treat multidrug-resistant or multidrug-tolerant bacteria against which conventional antibiotics are not effective. However, their therapeutic applications are often hampered due to their low selectivity to bacterial over mammalian membranes or their potential for cross-resistance to a broad spectrum of cationic membrane-active antimicrobial agents. We discovered that the diarylurea derivative compound PQ401 has antimicrobial potency against multidrug-resistant and multidrug-tolerant Staphylococcus aureus . PQ401 selectively disrupts bacterial membrane lipid bilayers in comparison to mammalian membranes. Unlike cationic membrane-active antimicrobials, the neutral form of PQ401 rather than its cationic form exhibits maximum membrane activity. Overall, our results demonstrate that PQ401 could be a promising lead compound that overcomes the current limitations of membrane selectivity and cross-resistance. Also, this work provides deeper insight into the design and development of new noncharged membrane-targeting therapeutics to combat hard-to-cure bacterial infections.
Funding Information
  • HHS | National Institutes of Health (P01AI083214)
  • HHS | National Institutes of Health (P01AI083214)
  • National Research Foundation of Korea (2020R1C1C1008842)
  • National Research Foundation of Korea (2018R1A5A2025286)
  • National Research Foundation of Korea (2017M3A9E4077234)
  • Agency for Science, Technology and Research
  • Agency for Science, Technology and Research

This publication has 102 references indexed in Scilit: